Array Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

ARRY 7.52 +0.14 (1.90%)
price chart
Why Array Biopharma Inc's Shares Skyrocketed
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Form 8-K ARRAY BIOPHARMA INC For: Jan 19  StreetInsider.com
Array BioPharma nabs global rights to Novartis cancer drug  Seeking Alpha (registration)
Biggest Movers in Healthcare Stocks Now – MNTA ALXN ARRY IPXL
Array Biopharma Inc (ARRY): ARRY stock is up 1.9% today. Impax Laboratories (IPXL): IPXL stock is up 1.6% today. China Biologic Products (CBPO): CBPO stock is up 1.3%, marking the third consecutive day the stock has increased.
Why Shares in Array BioPharma, Inc. Are Soaring Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Array BioPharma's (ARRY) CEO Ron Squarer on Q3 2015 Results -- Earnings ...  Seeking Alpha
Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015  MarketWatch
Does This 50% Price Target Hike For Array BioPharma Inc. Make Sense?
What: Shares of Array BioPharma (NASDAQ: ARRY ) , a biopharmaceutical company focused on developing novel small molecule cancer drugs, surged just shy of 10% on Monday following a hefty price target hike from brokerage firm Stifel Nicolaus.
Array Biopharma Inc. (NASDAQ:ARRY) Is going to Buy Worldwide Rights  Inside Trade
Why Array BioPharma Inc. Shares Skyrocketed 51% in January
What: Shares of Array BioPharma (NASDAQ: ARRY ) , a biopharmaceutical company that's focused on developing novel drugs to fight cancer, skyrocketed by 51% in January, based on data from S&P Capital IQ, after announcing a pipeline acquisition from ...
Today's Hot Stocks: Charter Communications, Inc. (NASDAQ:CHTR), Array ...
Array Biopharma Inc (NASDAQ:ARRY) jumped 10% in pre-market trading on Monday after it reported net income for the third quarter of $58.3 million, or $0.37 per share, compared to a net loss of $24.9 million, or $0.20 per share, for the same period in ...
Array BioPharma Inc. Analyst Price Target Update
Array BioPharma Inc. (NASDAQ:ARRY) stock has received a short term price target of $ 11 from 6 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $2.45.
Closing Bell Reports: Olin Corp. (OLN), Array BioPharma, Inc. (ARRY), Swift ...  WallStreet Scope
4 Notable Runners: Array Biopharma (ARRY), State Street (STT), Tesoro (TSO ...  Techsonian (press release)
Healthcare Sector Movers: Array BioPharma, Inc. (ARRY), Agilent Technologies ...
Array BioPharma, Inc. (ARRY) has changed by 1.63% today (change from open of 1.63%) as of 2pm today trading at a volume of 869,029 shares.
Hot Small Cap Stocks to Track - Array Biopharma (ARRY), NeoPhotonics (NPTN ...  Techsonian (press release)
Notable Earnings: Comcast (CMCSA), Cognizant (CTSH), Cyan, Inc. (CYNI ...
On valuation measures, Array BioPharma Inc. shares have a P/E to growth ratio of (8.93). The median Wall Street price target on the name is $10.00 with a high target of $15.00.
Benzinga's Top #PreMarket Gainers  Benzinga
Top Gainers #Pre-market May 4 - CYNI, ARRY, CTSH, ON, IMMU  FxPips.com
Technical Scrutiny on Biotech Stocks -- ARIAD Pharma, Array BioPharma, Enzon ...
Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Array BioPharma Inc. (NASDAQ: ARRY), Enzon Pharmaceuticals Inc. (NASDAQ: ENZN), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), and ...